Front Row Advisors’s Ambev ABEV Stock Holding History

Front Row Advisors’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-49	Closed	–	–	1008
2018 Q1	$0	Hold	49	–	–	﹤0.01%	941
2017 Q4	$0	Buy	+49	New	+$314	﹤0.01%	841

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MNG

Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Front Row Advisors's ABEV Position: Q2 2018 in Review

Front Row Advisors sold out of Ambev (ABEV) in Q2 2018, closing a stake of 49 shares.

Front Row Advisors first reported a position in ABEV in Q4 2017 and held it in 2 quarters. The position peaked at $0 in Q1 2018. 337 funds tracked by Wall St. Rank hold ABEV as of Q2 2018.

Front Row Advisors reported no remaining Ambev position as of Q2 2018 after selling out during the quarter.
Front Row Advisors sold 49 Ambev shares in Q2 2018.
Front Row Advisors first reported a position in Ambev in Q4 2017 and held it in 2 quarters.
Front Row Advisors's Ambev position peaked at $0 in Q1 2018.
337 funds tracked by Wall St. Rank held Ambev as of Q2 2018.

Based on Front Row Advisors's 13F filing for Q2 2018, filed 31 Jul 2018.